Embedding a Quality Framework for medication safety standards in delirium and dementia: A Singapore Study in a geriatric psychiatry liaison service

B. Balasundaram, S. Y. Loh, B. H. Rosario, M. H. Tun, C. Ooi, Fuyin Li, D. Bishara
{"title":"Embedding a Quality Framework for medication safety standards in delirium and dementia: A Singapore Study in a geriatric psychiatry liaison service","authors":"B. Balasundaram, S. Y. Loh, B. H. Rosario, M. H. Tun, C. Ooi, Fuyin Li, D. Bishara","doi":"10.56392/001c.87943","DOIUrl":null,"url":null,"abstract":"Research on prescribing processes for psychotropic medication review in older adult patients with severe behavioural symptoms of delirium and dementia appears limited. We aimed to improve and achieve 100% clinical documentation of psychotropic medication reviews against defined medication safety standards in older adult patients in geriatric wards with delirium occurrence and dementia without delirium referred to the geriatric psychiatry liaison service. The secondary aim evaluated any reduction in psychotropic medications as defined by medication safety standards by comparing pre-and post-assessments. A baseline measurement in April 2022 showed no documentation records of the study’s first three standards. PDSA methodology was employed to evaluate whether a medication review occurred following the creation and implementation of medication safety standards 1 to 4 in cycle one and adding the fifth standard in cycle 2. The first, second and third standards were medication reviews of all hypnotics, antipsychotics, and psychotropic polypharmacy. The fourth standard reviewed the anticholinergic burden scores measured by the Anticholinergic Effect on Cognition scale. The fifth standard reviewed blood pressure and postural hypotension monitoring. Using a quality improvement framework that embeds defined medication safety standards as an intervention, we have demonstrated good documentation records for a medication review to improve psychotropic prescribing processes in the older adult’s psychiatry liaison service in geriatric wards in all standards in the 2 study cycles. There was a reduction in all psychotropic medications at post-assessment as defined by the medication safety standards 1 to 4 in at least one cycle in delirium occurrence and dementia without delirium, except for zopiclone in delirium. The study’s findings in a geriatric ward setting in a public hospital in Singapore support the feasibility of embedding medication review using defined medication safety standards to improve psychotropic medication prescribing processes in older adults with delirium occurrence and dementia without delirium.","PeriodicalId":72776,"journal":{"name":"Delirium communications","volume":"C-34 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Delirium communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56392/001c.87943","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Research on prescribing processes for psychotropic medication review in older adult patients with severe behavioural symptoms of delirium and dementia appears limited. We aimed to improve and achieve 100% clinical documentation of psychotropic medication reviews against defined medication safety standards in older adult patients in geriatric wards with delirium occurrence and dementia without delirium referred to the geriatric psychiatry liaison service. The secondary aim evaluated any reduction in psychotropic medications as defined by medication safety standards by comparing pre-and post-assessments. A baseline measurement in April 2022 showed no documentation records of the study’s first three standards. PDSA methodology was employed to evaluate whether a medication review occurred following the creation and implementation of medication safety standards 1 to 4 in cycle one and adding the fifth standard in cycle 2. The first, second and third standards were medication reviews of all hypnotics, antipsychotics, and psychotropic polypharmacy. The fourth standard reviewed the anticholinergic burden scores measured by the Anticholinergic Effect on Cognition scale. The fifth standard reviewed blood pressure and postural hypotension monitoring. Using a quality improvement framework that embeds defined medication safety standards as an intervention, we have demonstrated good documentation records for a medication review to improve psychotropic prescribing processes in the older adult’s psychiatry liaison service in geriatric wards in all standards in the 2 study cycles. There was a reduction in all psychotropic medications at post-assessment as defined by the medication safety standards 1 to 4 in at least one cycle in delirium occurrence and dementia without delirium, except for zopiclone in delirium. The study’s findings in a geriatric ward setting in a public hospital in Singapore support the feasibility of embedding medication review using defined medication safety standards to improve psychotropic medication prescribing processes in older adults with delirium occurrence and dementia without delirium.
嵌入谵妄和痴呆症用药安全标准的质量框架:新加坡老年精神科联络服务研究
对有严重谵妄和痴呆行为症状的老年患者进行精神药物处方审查的研究似乎很有限。我们的目标是改进老年病房中出现谵妄症状和痴呆但未出现谵妄症状的老年患者的精神药物处方审查,使其达到 100%的临床记录符合规定的用药安全标准。次要目的是通过比较前后评估结果,评估药物安全标准所规定的精神药物用量是否有所减少。2022 年 4 月的基线测量结果显示,研究的前三个标准均无文件记录。在第一周期创建和实施用药安全标准 1 至 4,并在第二周期增加第五项标准后,采用 PDSA 方法评估是否进行了用药审查。第一、第二和第三条标准是对所有催眠药、抗精神病药和精神药物进行用药审查。第四个标准是通过抗胆碱能药物对认知的影响量表测量抗胆碱能药物负担得分。第五项标准审查了血压和体位性低血压监测。我们采用了质量改进框架,将定义的用药安全标准作为干预措施,在两个研究周期内,我们在老年病房的老年人精神科联络服务中展示了良好的用药审查文件记录,改善了所有标准中的精神药物处方流程。在谵妄发生和无谵妄的痴呆症患者中,除了佐匹克隆在谵妄患者中的应用外,所有精神药物在评估后至少有一个周期减少了用药安全标准 1 至 4 所定义的药物。该研究在新加坡一家公立医院的老年病房环境中进行,其结果支持了采用规定的用药安全标准进行用药审查,以改善有谵妄发生和无谵妄痴呆的老年人精神药物处方过程的可行性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信